81% of Patients Believe Biosimilars and Biologics Should Require Same Type and Level of Testing

09:30 EDT 29 Jun 2017 | Businesswire
Health Stories Project – Insights

– Health Stories Project – Insights Survey of 300 Autoimmune Patients and Two Patient Forums Explored Awareness of and Attitudes Toward Biosimilars

– First Report in Research Offering Now Available for Purchase with Full Results –

Health Stories Project – Insights, a new healthcare market intelligence company dedicated to magnifying the patient voice to influence decision making and support movement toward patient-centricity, has announced the launch of its Insights Reports with the publication of a report titled "Biosimilars: Patient Understanding and Attitudes." The research showed that 81% of patients believe biosimilars and biologics should require the same type and level of testing, and the response is even higher among women (83%) and consumers 55 and older (92%). Among patients not using biologics, more than half said they were interested in learning more about biosimilars.

“As biosimilars are poised for expanded adoption, we knew the time was right to ask autoimmune patients who are either already taking biologics or have conditions that could result in treatment with biologics about their understanding of, concerns about and willingness to take biosimilars,” said Jo Anne Jensen, Vice President of Health Stories Project – Insights. “Our findings were very revealing, leading us to conduct two follow-up forums with both biologic-experienced and biologic-naive patients. These additional in-depth discussions explored patient feelings and the factors that influence their treatment.”

All findings from Health Stories Project – Insights recent biosimilars research are detailed in the newly published report, "Biosimilars: Patient Understanding and Attitudes," now available on the Health Stories Project – Insights website,

This report is based on the findings of a September-October 2016 survey and two discussion forums exploring the views of 300 patients with autoimmune conditions to assess their awareness of and attitudes toward biosimilars. Participants included a wide range of conditions, treatment profiles, ages, genders, and geographies. Topics addressed include:

  • Impact of patient condition on understanding of biosimilars
  • Awareness and understanding of biologics and biosimilars
  • Ability to differentiate between biologics and biosimilars
  • Testing of biologics and biosimilars
  • Factors that affect treatment choices
  • Trusted sources of information
  • Reactions to physician switching to a biosimilar
  • Reactions to pharmacy substitution of a biosimilar product

Health Stories Project – Insights is a new healthcare market intelligence company dedicated to capturing, measuring, analyzing and sharing the patient perspective. The company gathers information compliantly and privately through both custom and syndicated research projects, including online surveys, video interviews and virtual focus groups. It publishes reports, white papers and infographics to deliver research findings. Based in Seattle, Health Stories Project – Insights is part of the Health Perspectives Group of companies.

“As our newest Health Perspectives Group division, Health Stories Project – Insights fills a unique need within the biopharmaceutical and healthcare industries,” said Cheryl Lubbert, President and CEO of Health Perspectives Group. “Using industry best practices and analysis, Health Stories Project – Insights gives patients opportunities to share their personal health stories and magnifies their voices to influence industry decision-making and support the shift toward patient-centricity.”

About Health Stories Project – Insights

Health Stories Project - Insights, a division of the Health Perspectives Group of companies, creates a forum that empowers patients to share their stories with a broad range of stakeholders throughout the healthcare community. By placing individual experiences and opinions into a research context, we support industry movement toward patient engagement and, ultimately, patient centricity. For more information, visit

About Health Perspectives Group

The Health Perspectives Group of companies creates healthcare engagement and technology solutions to capture and promote the consumer perspective, making compliant, patient-centered action possible. By elevating the healthcare conversation, Health Perspectives Group believes consumers will gain the knowledge and confidence they need to navigate the complexities of their own health — and ultimately help transform the healthcare industry. For more information, visit

For HSP Insights
Kathryn Morris, 914-204-6412


More From BioPortfolio on "81% of Patients Believe Biosimilars and Biologics Should Require Same Type and Level of Testing"

Quick Search

Relevant Topics

Autoimmune Disorders
Autoimmune disorders are conditions that occurs when the immune system mistakenly attacks and destroys healthy body tissue. There are more than 80 different types of autoimmune disorders. Normally the immune system's white blood cells help protect ...

Biotechnology Products
BioPortfolio lists over 550 biotechnology products - please open Direct topic pages: Actos Advair Biopharmaceuticals Biosimilars Biotherapeutics GMO Crops Lipitor ...